Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-06-2007 | Letter to the Editor

Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin)

Authors: Focke Ziemssen, Christoph M. Deuter, Nicole Stuebiger, Manfred Zierhut

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 6/2007

Excerpt

Dear Editor: …

Rothova A (2002) Medical treatment of cystoid macular edema. Ocul Immunol Inflamm 10:239–246PubMedCrossRef

Lardenoye CW, van Kooij B, Rothova A (2006) Impact of macular edema on visual acuity in uveitis. Ophthalmology 113:1446–1449PubMedCrossRef

Mason JO, Albert MA, Vail R (2006) Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina 26:356–357PubMedCrossRef

Abraham-Marin ML, Cortes-Luna CF, Alvarez-Rivera G, Hernandez-Rojas M, Quiroz-Mercado H, Morales-Canton V (2006) Intravitreal bevacizumab therapy for neovascular age-related macular degeneration: a pilot study. Graefe Arch Clin Exp Ophthalmol E-pub

Clauss M, Gerlach M, Gerlach H et al (1990) Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535–1545PubMedCrossRef

Hattori K, Dias S, Heissig B et al (2001) Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193:1005–1014PubMedCrossRef

Reinders ME, Sho M, Izawa A et al (2003) Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 112:1655–1665PubMedCrossRef

Jonas JB (2005) Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol Scand 83:645–663PubMedCrossRef

Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU (2006) Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol Scand 84:833–834PubMedCrossRef

10.

Deuter CME, Koetter I, Guenaydin I, Stuebiger N, Zierhut M (2006) Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? Retina 26:786–791PubMedCrossRef

Title: Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin)
Authors: Focke Ziemssen
Christoph M. Deuter
Nicole Stuebiger
Manfred Zierhut
Publication date: 01-06-2007
Publisher: Springer-Verlag
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 6/2007
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-006-0512-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin)

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2007

Ocular penetration of caspofungin in a rabbit uveitis model

Enlargement of optic nerve resembling orbital mass in case of optic neuritis

T. Reinhard and F. Larkin (eds): Cornea and External Eye Disease

The phenomenon of “sticky” silicone oil

Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): recruitment list evaluation. Study report no. 2

Online optical coherence pachymetry to evaluate intraoperative ablation parameters in LASIK